Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
PMCPA ruled GSK’s Trelegy HCP webpage claim “greater exacerbation reduction vs another single-inhaler triple therapy” was ambiguous and misleading, implying significance without…
PMCPA ruled GSK’s “Trevor trusts Trelegy” claim on an HCP website was ambiguous, misleading and unsubstantiated (Clauses 6.1, 6.2, 5.1). No breach…
Senior UK-based AstraZeneca employees ‘liked’ LinkedIn posts linking to press releases about Imfinzi combinations and trial results. The PMCPA ruled promotion to…
Six amalgamated complaints. Breaches found for a UK “think tank” meeting (uncertified promotional content; ‘cure’ implication) and LinkedIn likes/reposts (pre-authorisation promotion; public…
Complaint alleged a senior AstraZeneca leader’s LinkedIn ‘About’ section promoted POMs to the public and referenced unlicensed indications/trials. Panel ruled no breach…
Complaint said a Trixeo HCP eligibility checklist omitted SmPC counselling/stop-treatment text for acute narrow-angle glaucoma. Panel found breaches, but Appeal Board overturned:…
A senior UK-based AbbVie medical affairs employee referenced Botox on a national TV quiz show. PMCPA ruled this promoted a POM to…
Complaint said a Rinvoq HCP webinar registration page gave dosing but omitted the SmPC grapefruit avoidance warning. Panel found the page wasn’t…
PMCPA case AUTH/3728/1/23: complaint alleging promotion of Zeposia (ozanimod hydrochloride) against Bristol Myers Squibb. Outcome: no breach; matter not within the scope…
AbbVie admitted an HCP registration webpage went live in a version that differed from the certified copy after an agency uploaded the…
Grünenthal admitted a market access employee calling on HCPs did not take the ABPI exam modules within the first year of employment.…
Ex-employee alleged BI/Lilly alliance PMAP SOP and training were not accessible/controlled and that “agreements outside PMAP” existed. Panel found allegations not evidenced;…
Daiichi Sankyo’s Nustendi promotional website omitted a contraindication (with statin in active liver disease/persistent transaminase elevations) on the tolerability page. Panel found…
Daiichi Sankyo facilitated an AF digital diagnosis opinion article on an independent news site, but its involvement was only disclosed at the…
A third-party newsletter ran a “Sponsored” block linking to AZ’s Forxiga promotional microsite, but the email didn’t name AstraZeneca, didn’t make the…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
